Christopher Kloss

Christopher Kloss

Company: Merck & Co

Job title: Assistant Principal Scientist, Cell & Gene Therapy


Gene Modifications to Achieve Long-term Engraftment 3:00 pm

• Discuss the ability of cells to engraft, how does mismatch (major or minor compatibility) limit engraftment? • Review novel technology to track cells in vivo to reliably measure persistency and trafficking • Understand the performance of cells in vivo to help inform product modifications with confident endpointsRead more

day: Track A - Day 1 - 3PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.